Navigation Links
Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
Date:4/7/2009

5 7,404,011 Total Assets $28,997,639 $20,246,679 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts payable and accrued expenses $2,191,976 $537,780 Customer advances 2,592,250 2,412,846 Short-term bank loan -- 519,544 Value-added tax payable 527,103 298,032 Income tax payable 413,205 187,089 Total Current Liabilities 5,724,534 3,955,291 Commitment Stockholders' Equity Series A, convertible preferred stock, $0.001 par value, 5,000,000 shares authorized, 0 and 72,500 shares issued and outstanding at December 31, 2008 and 2007 -- 725,000 Undesignated preferred stock, $.001 par value, 5,000,000 shares authorized, none issued and outstanding -- -- Common stock, $.001 par value, 100,000,000 shares authorized, 23,240,899 shares issued and outstanding at December 31, 2008 and 2007 23,241 22,152 Additional paid-in capital 10,430,168 8,244,017 Statutory reserves 1,585,383 902,113 Retained earnings 10,996,655 6,451,623 Accumulated other comprehensive income (loss) 237,658 (53,517) Total Stockholders' Equity 23,273,105 16,291,388 Total Liabilities and Stockholders' Equity $28,997,639 $20,246,679

ABOUT BIOSTAR PHARMACEUTICALS, INC.

BioStar Pharmaceuticals, Inc., through its wholly-own
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
2. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
3. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
4. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
5. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
6. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
7. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
8. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
9. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
10. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
11. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Mass. , July 1, 2015   ... most frequently cited advantages of Otezla are its ... safety profile, as reported by surveyed rheumatologists. Otezla ... launched for the treatment of active psoriatic arthritis ... The current standard of care includes conventional oral ...
(Date:7/1/2015)... , July 1, 2015  Axovant Sciences Ltd. ... on the treatment of dementia, today announced that ... July 22 at 5:45 p.m. EDT following its ... Association International Conference 2015 (AAIC). ... , Dr. Lawrence Friedhoff , Chief ...
(Date:7/1/2015)... Indianapolis, IN (PRWEB) , ... July 01, 2015 , ... ... the 2015 BIO International Convention in Philadelphia, PA. , The presentation took ... milestones and outlined the plans for the development of APX3330 for the treatment of ...
(Date:6/30/2015)... ... June 30, 2015 , ... Students and faculty from ... first half of “Integrative Biotechnology,” an applied biotechnology course team-taught by faculty members ... course combines students from both universities and is taught on both continents. , ...
Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ... and commercialization of novel drugs in the,therapeutic areas ... it will host a conference call and webcast ... May 7, 2008 at 10:00,a.m. (EDT). Michael T. ...
... Michael Strahan and Lawrence Tynes, celebrity chef Sam Talbot ... benefit, NEW YORK, May 1 The stars ... annual D.R.E.a.M.S. in the City,fundraiser, to be held at ... p.m. to 9:30 p.m. Already confirmed on the guest ...
... Group, Inc. (OTC,Bulletin Board: MDXG) announced today that ... been appointed to its Board of,Directors, effective April ... D,Alonzo, Chief Executive,Officer, stated "We are delighted to ... our Board. Ron,s financial acumen and his,experience with ...
Cached Biology Technology:Advanced Life Sciences to Host 2008 First Quarter Financial Results Conference Call and Webcast 2Advanced Life Sciences to Host 2008 First Quarter Financial Results Conference Call and Webcast 3Celebrities to Attend and Present at D.R.E.a.M.S in the City 2MiMedx Group, Inc. Adds Ronald G. Wallace to Board of Directors 2
(Date:6/17/2015)... BEACH GARDENS, Fla. , June 17, 2015 ... management solutions, today announced that its U.are.U ® ... Togo,s Eateries, Inc., a ... fast casual sandwich chain, to increase security, improve ... Crossmatch fingerprint readers enable instant, non-repudiable identity confirmation ...
(Date:6/16/2015)... GOTHENBURG, Sweden , June 16, 2015 ... including all touch fingerprint sensors in the company,s portfolio from ... . Deliveries are planned to mainly take place during the ... manufacturers in Asia . Jörgen ... another evidence of    the   growing interest from smartphone ...
(Date:6/15/2015)... June 15, 2015 A new report ... reveals the majority of US consumers using mobile banking applications ... such as fingerprint and voiceprint, instead of having to prove ... to Telstra,s " Mobile Identity   -   The Fusion ... with smartphones now the primary channel used by Gen X ...
Breaking Biology News(10 mins):Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4
... when cosmetics, shampoos, skin creams, and other personal care ... to plant-derived extracts and other natural ingredients government ... the silicone-based ingredients long used in these products. That,s ... of Chemical & Engineering News (C&EN), ACS, weekly newsmagazine. ...
... Weizmann Institute scientists have added another piece to the obesity ... active in a small part of the brain contributes to ... . Prof. Ari Elson and his team in ... with female mice that were genetically engineered to lack this ...
... A group of 12 biology educators at ... argues in the May issue of BioScience ... and teaching of ecology conducted at these institutions. ... dedicated to continental-scale observations, argues that better coordination ...
Cached Biology News:Weizmann Institute scientists discover: A protein that contributes to obesity 2
... 384 is a compact and self-contained ... is a unique flow-through device, which ... included wash system. Optional refill ... system. Will be upgradable to ...
... Eclipse C1 Plus is a modular confocal ... imaging with an ultra-compact and lightweight design. ... C1 Plusboost optical performance to 400nm andits ... alsoincludes support for X and Y scan ...
This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
... Motic's amazing new range of ergonomic ... and with a small footprint. The DM-BA200 ... Optical System and an exchangeable USB2.0 plug ... infinity-corrected E-Plan Achromat objectives mounted on a ...
Biology Products: